Home › NDC Lookup › RxCUI directory › RxCUI 1718934

Olanzapine 210 MG Injection — RxCUI 1718934

Name: Olanzapine 210 MG Injection (RxCUI 1718934)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1718934 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1718934

Official nameOlanzapine 210 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asolanzapine 210 MG (as olanzapine pamoate monohydrate 483 MG) Injection; OLANZapine 210 MG Extended Release Injection

FDA products mapped3

Package NDCs mapped3

Reported Medicaid activity (SDUD)185 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Olanzapine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Olanzapine helps bring certain brain chemicals — mainly dopamine and serotonin — back into balance. Depending on what it's prescribed for, it can reduce symptoms of psychosis like...
What exactly is olanzapine supposed to do for me?
Honestly, yes — weight gain and changes in blood sugar and cholesterol are real and well-documented with olanzapine. Some people gain a significant amount of weight. Blood sugar ca...
Will olanzapine make me gain weight or affect my blood sugar?

📖 Read our full Olanzapine guide →

🕸️ Concept Web — How Olanzapine 210 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Olanzapine 210 MG Injection RxCUI 1718934 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Olanzapine 61381 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Zyprexa 135423 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Olanzapine Injection 1718924 SCDF
- Olanzapine Injectable Product 1159556 SCDG
- Olanzapine Injection [Zyprexa] 1718927 SBDF
- Zyprexa Injectable Product 1186671 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Olanzapine 210 MG 1718933 SCDC
- Olanzapine 210 MG Injection [Zyprexa] 1718936 SBD
- Olanzapine 210 MG [Zyprexa] 1718935 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Olanzapine 210 MG SCDC · 1718933
Olanzapine Injection SCDF · 1718924
Olanzapine Injectable Product SCDG · 1159556

Brand-Name Concepts

Olanzapine 210 MG Injection [Zyprexa] SBD · 1718936
Olanzapine 210 MG [Zyprexa] SBDC · 1718935
Olanzapine Injection [Zyprexa] SBDF · 1718927
Zyprexa Injectable Product SBDG · 1186671
Zyprexa BN · 135423

📦 FDA Products & Package NDCs

3 products · 3 package NDCs

3 package NDCs map to RxCUI 1718934 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
61269-0660-20	1 KIT in 1 CARTON (61269-660-20) * 1.4 mL in 1 VIAL * 3 m...	ZYPREXA Relprevv	H2-Pharma LLC	2010-03-01
61269-0661-20	1 KIT in 1 CARTON (61269-661-20) * 2 mL in 1 VIAL * 3 mL...	ZYPREXA Relprevv	H2-Pharma LLC	2010-03-01
61269-0662-20	1 KIT in 1 CARTON (61269-662-20) * 2.7 mL in 1 VIAL * 3 m...	ZYPREXA Relprevv	H2-Pharma LLC	2010-03-01

Observed labelers: H2-Pharma LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J2358	Olanzapine long-acting inj	3	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.